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Abstract 
BACKGROUND: Minor recurrent aphthous stomatitis (MiRAS) is one of the most common, recurrent, and painful 
mucosal pathological condition. It is characterised by round or shallow oval ulcers, less than 10 mm in diameter, 
surrounded by a thin erythematous halo. It involves non-keratinized mucosa such as the labial and buccal 
mucosa, the ventral surface or borders of the tongue and the floor of the mouth, but it is uncommon to occur on 
the keratinised mucosa. It heals spontaneously within 10-14 days without scarring. There is no curative remedy to 
prevent its recurrence; also, available modalities only reduce the symptoms and severity of the lesion.  
AIM: Since these lesions may be extremely painful, we decided to estimate the pain-relieving and healing 
properties of low energy level laser therapy using diode laser 660 nm on MiRAS. 
MATERIAL AND METHODS: Twenty healthy patients suffering from minor aphthous ulcers were randomly 
selected from the Out-Patient Clinic of Oral Medicine Department, Faculty of Dentistry, Alexandria University. 
They were equally divided into two groups, study group who received 660 nm diode laser irradiation while the 
control group received placebo (sodium bicarbonate rinse). The visual analogue scale, size reduction, 
effectiveness indices and functional disorders were compared between the groups. 
RESULTS: Both groups presented a statistically significant difference from baseline to follow up periods. But, 
diode laser 660 nm treatment showed more remarkable improvements in reduction of healing time, pain and 
lesion size. 
CONCLUSION: We concluded that diode laser 660 nm should be further considered as an effective alternative 
therapeutic regimen to patients who suffer from recurrent aphthous stomatitis. 
 
 
 
 
 
 
Introduction 
 
The minor recurrent aphthous stomatitis 
(MiRAS) is one of the most common forms of the 
recurrent aphthous stomatitis (RAS) [1], [2]. It has a 
higher incidence in children and adult females [3], [4] 
with a notable association with the socioeconomic 
status [5]. It is known as a pathological condition which 
is presented by painful recurrent rounded or ovoid 
shallow mucosal ulceration, less than 10 mm in 
diameter, with yellow or grey floor surrounded by thin 
erythematous halo margins [2], [3]. It usually includes 
the non-keratinized mucosa such as the labial and 
buccal mucosa, the ventral surface and lateral borders 
of the tongue and the floor of the mouth. The 
exposure of nerve endings leads to pain, burning or 
soreness sensation [6] which affects the patient’s 
ability to eating and speaking. It heals spontaneously 
within 10-14 days; it recovers without leaving scars 
[2].  
Although many studies have been devoted to 
clarifying the aetiology and pathogenesis of RAS 
revealing the relation to cell-mediated mechanisms 
[4], the specific immunopathogenesis is unknown [7]. 
However, local and systemic factors, genetic impacts, 
immunologic influences, and microbial causes may 
play a role in the pathogenesis of RAS. Since the 
aetiology is unidentified, the diagnosis is completely 
based on the history and clinical findings [8]. 
There is no curative remedy to avoid the 
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recurrence of these ulcers; its management depends 
on the supportive protocol targeting the relief of RAS 
symptoms [8]. Though, varies medications have been 
developed including local and systemic anti-
inflammatory, antibacterial and immunosuppressive 
agents, patients complained of considerable 
discomfort [8].  
Recently, the application of the low-level laser 
therapy (LLLT) has been expanding for healing and 
pain control of various pathologic conditions [9], [10]. 
LLLT emits the light of a single wavelength through 
non-thermal or photochemical cell reactions which are 
called biostimulation reaction. Once the target cells 
have absorbed these photons, a cascade of 
biochemical events happens inducing rapid wound 
healing [11]. 
The diode laser is one of the LLLT where 
semi-conductor diode acts as the active medium to 
emit light [12]. It provides more benefits than other 
lasers because it has a small size, a wide range of 
spectrum and transmission through fibre optics [13]. 
Their application produces biomodulatory and 
analgesic effects on the tissue without thermal 
damage or ablation [14]. As these lesions may be 
tremendously painful, we aimed to estimate the pain-
relieving ability and healing efficiency of LLLT using 
diode laser 660 nm on MiRAS as easy, less time-
consuming and non-chemical therapy. 
The purpose of this study was to evaluate the 
clinical effect of diode laser on the treatment of minor 
aphthous ulcer (MRAS). 
 
 
Material and Methods  
 
The study proposal was evaluated and 
accepted by the Ethical Committee of Faculty of 
Dentistry, Alexandria University, Alexandria, Egypt. 
Informed consent was accomplished after delivering 
all information to the study cases. 
 
Recruitment of subjects 
Twenty patients with clinically diagnosed 
MiRAS of both sexes were selected from the 
outpatient clinics of the Oral Medicine Department, 
Faculty of Dentistry, Alexandria University in 
randomised parallel study design. They were chosen 
according to the following criteria. 
 
Inclusion criteria 
- Patients’ age ranges from 20 to 40 years. 
- Patients had minor aphthous ulcers with 
onset less than two days. 
- No treatment with any modality for at least 1 
month before the start of the clinical trial.  
- Willingness to participate in the present 
clinical study. 
 
Exclusion criteria 
- Patients who had physiological or mental 
diseases. 
- Patient under anticoagulants, anti-
inflammatory or immunosuppressant medications. 
- Pregnant or postmenopausal females. 
- Smoker patients. 
 
Pre-study assessment 
Detailed pre-operative data were documented 
from all allocated patients including their names, ages, 
occupations, medical histories and dental histories. 
Also, the onset, duration and severity of the pain of 
the ulcer were reported. Extra-oral examinations were 
done including the dermal and ocular examinations to 
exclude Behçet syndrome. However, the intraoral 
examination and diagnosis of MiRAS were based on 
clinical features of solitary shallow round mucosal 
ulcers surrounded by inflammatory halos, with the size 
of less than 10 mm in diameter [4] and positive history 
of recurrence. 
 
Study procedure  
A randomised selection was made to the 
included patients, and they were separated into two 
equal groups; Group A (study group) contained ten 
patients who received diode laser treatment. They 
were guided to wear protective eyeglasses matched 
to our laser wavelength to avoid radiation hazards. 
Then, diode laser (wavelength 660 nm, intensity 100-
130 mW/cm, energy 4 J/cm
2
) was performed in the 
first visit only as shown in Figure 1. The laser beam 
was delivered using an optical fibre of 2 mm diameter 
which was applied perpendicularly to the mucosa. The 
ulcer and 2 mm of its surrounding borders were 
illuminated with several spots (40 sec/spot). The 
technique was painless and did not necessitate any 
anaesthesia. While Group B (control group) included ten 
patients who received a placebo. They were instructed 
to rinse a diluted sodium bicarbonate oral 4 times/day 
(one teaspoon in a medium glass of water). 
 
Clinical Evaluation 
The responses of group A and group B were 
assessed according to symptoms (pain) scores and 
sign scores (lesion size) using: 
A) Subjective pain assessment of the ulcer  
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A visual analogue scale (VAS) was used 
consisting of a 10-cm horizontal line starting with a 
pole of no pain to reach the end pole presenting the 
unbearable pain [15]. Individuals were requested to 
mark the point on the horizontal line that best signifies 
their pain level. 
 
Figure 1: Minor aphthous lesion during phototherapy using diode 
laser 660 nm 
 
B) Objective assessment of the ulcer sizes 
The index ulcer's size was estimated on the 
treatment of day one, four and six. The maximum and 
minimum diameters of an oval-shaped ulcer were 
measured by a calibrated periodontal probe 
(University of Michigan 0 probe) as shown in Figure 2. 
Then, the two dimensions were calculated to 
exemplify the cross-sectional areas of the lesion. 
 
Figure 2: The measurements of the largest and smallest diameters 
of MiRAS on the labial mucosa of the upper lip, using a calibrated 
periodontal probe 
 
C) The effectiveness indices (EI) 
assessment of healing 
The effectiveness indices (EI) of the pain 
improvement and ulcer size were analyzed with a 
formula EI = [(V1 – V4 or V6) ÷ V1] × 100 % (16) 
where V4 and V6 referred to the values which were 
measured at day 4 visit and day 6 visit, while V1 
referred to the baseline value which was measured 
before the study entry.  
The effectiveness indices were evaluated on 
a 4-Rank scale [17]: 
 Rank (1): Heal: EI ≥ 95%. 
 Rank (2): Marked improvement: El < 95%, 
but ≥ 70%. 
 Rank (3): Moderate improvement: EI < 70%, 
but ≥ 30%.  
 Rank (4): No improvement: EI < 30%. 
D) Post-operative complications’ 
assessment  
Participants were asked to grade the VAS of 
the severity of their postoperative complications (such 
as the presence of pain, oedema, and functional 
disorders) in numbers from 1 to 10 in the first, second 
and third visits, according to the following: 
1-2 no postoperative complications; 
3-5 mild postoperative complications; 
5-7 moderate postoperative complications; 
 8-10 severe postoperative complications.  
The patients were reviewed for follow up 
periods from day 1 to day 6. Clinical photographs 
were taken before treatment and during follow up 
periods.  
 
Statistical analysis 
Statistical analyses were implemented by the 
SPSS software (SPSS Inc, Chicago, IL). The 
Kolmogorov–Smirnov test was performed to analyse 
the data distribution. Results were expressed as 
median or mean ± SD and t-test to appraise the 
significance of any variances between the two study 
groups. All correlations were estimated, and the 
statistical significance was set at p < 0.05.  
 
 
 
Results  
 
In this clinical trial, 20 patients (13 males and 
7 females) with clinically diagnosed MiRAS were 
allocated equally into 2 groups. Table 1 shows the 
patients characterisation regarding the sex and age 
distribution; no statistically significant differences were 
observed between the study and control groups in sex 
or age distribution (p = 0.66 and 0.49 respectively). 
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Table 1: Sex and age distribution of the study sample 
 Study group Control group Test p-value 
Sex 
Male 6 (60) 7 (70) 
- 0.66 
Female 4 (40) 3 (30) 
Age  
Min-max 21 - 40 21 - 40 
0.71 0.49 
Mean ± SD 30.1 ± 6.9 28.1 ± 5.8 
 
Table 2 displays the comparison between the 
two sample groups regarding the pain scores at varies 
follow up visits. The differences in VAS pain score 
between the study and control groups at the beginning 
of days 1, 2 and 3 were 8.00 ± 0.51, 9.00 ± 0.58 and 
8.38 ± 0.72 respectively. However, the mean indices 
at day 4 in the study and control groups were 91.82 ± 
18.34 and 8.00 ± 13.98 while at day 6, all cases in the 
study group had effectiveness index = "100" and the 
mean in the control group was 48.00 ± 31.55. The 
differences between the study and control groups in 
the effectiveness indices for pain after the two periods 
were statistically significant (p < 0.0001 for both).  
Table 2: Comparison of VAS pain score between the two 
study groups at different follow-up periods 
 Effectiveness index 
Mean ± SD 
Z of MWU 
test 
P-value 
Study group Control group 
At day 1 2.00 ± 1.61 10.00 ± 0 4.14 < 0.0001* 
At day 2 1.00 ± 1.84 10.00 ± 0 4.23 < 0.0001* 
At day 3 0.82 ± 1.83 9.20 ± 1.40 4.12 < 0.0001* 
At day 4 91.82 ± 18.34 8.00 ± 13.98 4.12 < 0.0001* 
At day 6 100.00 ± 0 48.00 ± 31.55 3.55 < 0.0001* 
*Statistically significant at p ≤ 0.05; Mann Whitney U test used instead of t-test. 
 
Table 3 demonstrates the ulcers’ sizes 
between the comparative groups. At the beginning of 
the treatment, there was no statistically significant 
difference between both groups on day 1 (p = 0.76). 
Whereas, the differences in ulcers’ sizes between the 
study and control groups at days 4 and 6 were 
statistically significant (p = 0.008 and 0.001 
respectively). The differences in the study group in 
ulcer size between day1 and each of day 4 and day 6 
were statistically significant (p = 0.002 and 0.007 
respectively). However, the differences in the control 
group in ulcer size between day1 and day 4 were not 
statistically significant (p = 0.34) whereas the 
difference between day 1 and day 6 was statistically 
significant (p = 0.01).  
Table 3: Comparison of ulcer size in mm2 between the two 
study groups at different follow-up periods 
 Ulcer size 
Mean ± SD 
t-test p-value 
Study group Control group Difference 
Day 1 6.56 ± 3.17 6.10 ± 3.18 0.46 ± 1.46 0.31 0.76 
Day 4 2.44 ± 1.59 5.80 ± 3.01 3.36 ± 1.12 2.98 0.008* 
Day 6  0.17 ± 0.50 2.90 ± 1.73 2.73 ± 0.57 3.38 0.001* 
Paired t test (1-4 days) 
p value 
4.47 
0.002* 
1.00 
0.34 
 
WSR test (1- 6 days) 
p value 
2.68 
0.007* 
2.53 
0.01* 
*Statistically significant at p ≤ 0.05; Mann Whitney U test used instead of t-test; WSR test: 
Wilcoxon signed ranks test. 
 
Table 4 exhibits the levels of effectiveness 
index of pain reduction in the two study groups after 4 
and 6 days in which at day 4, all cases in the study 
group showed either “heal” or “moderate improvement 
“compared to the control group whose cases showed 
“moderate” or “no improvement” (p < 0.0001*). While 
at the sixth day, all cases in the study group were 
completely “healed”, which was in contrast with the 
control group where 2 cases were healed and the 
remaining cases showed either “moderate” or “no 
improvement” (p = 0.001*). 
Table 4: Comparison of levels of effectiveness index for pain 
reduction between the two study groups at different follow-up 
periods 
 Levels of effectiveness index 
N (%) 

2
 
p-value 
Study group Control group 
After 4 days Score 1 (heal) 9 (81.8) 0 18.33 
< 0.0001* Score 2 (marked improvement) 0 0 
Score 3 (moderate improvement) 1 (18.2) 1 (10) 
Score 4 (no improvement) 0 9 (90) 
After 6 days Score 1 (heal) 10 (100) 2 (20) 14.22 
0.001* Score 2 (marked improvement) 0 0 
Score 3 (moderate improvement) 0 5 (50) 
Score 4 (no improvement) 0 3 (30) 
WSR test 
p value 
1.41 
0.16 
2.46 
0.01* 
 
*Statistically significant at P ≤ 0.05; WSR test: Wilcoxon signed ranks test. 
 
Table 5 represents the comparison of levels 
of effectiveness index of the size reduction between 
the sample groups in the fourth and sixth days. At day 
4, there was a statistically significant difference in the 
levels of effectiveness index between the two groups. 
The study group showed one case healed and the 
remaining cases showed either marked or moderate 
improvement (Figure 3, and 4) compared to the 
control cases which showed one case had moderate 
improvement, and the remaining cases showed no 
improvement (p = 0.001*). While at the day 6, there 
was a statistically significant difference in the levels of 
effectiveness index between the two groups, the study 
group showed one case had remarkable 
improvement, and the remaining cases were healed, 
but the control cases showed one case had healed 
and most of the remaining cases showed either 
moderate or no improvement (p = 0.004*).  
Table 5: Comparison of levels of effectiveness index for size 
reduction between the two study groups at different follow-up 
periods 
 Levels of effectiveness index 
N (%) 

2
 
p-value 
Study group Control group 
After 4 
days 
Score 1 (heal) 1 (11.1) 0 15.56 
< 0.001* Score 2 (marked improvement) 3 (22.2) 0 
Score 3 (moderate improvement) 6 (66.7) 1 (10) 
Score 4 (no improvement) 0 9 (90) 
After 6 
days 
Score 1 (heal) 8 (88.9) 1 (10) 13.43 
0.004* Score 2 (marked improvement) 2 (11.1) 1 (10) 
Score 3 (moderate improvement) 0 6 (60) 
Score 4 (no improvement) 0 2 (20) 
WSR test 
p value 
2.60 
0.009* 
2.46 
0.01* 
 
*Statistically significant at p ≤ 0.05; WSR test: Wilcoxon signed ranks test. 
 
Table 6 and Figure 3 illustrate the comparison 
of functional disorders between the two study groups 
at various follow-up periods. The mean functional 
disorders scores in the study group were 2.45 ± 1.29 
on the first day, 1.73 ± 1.43 in the second day and 
1.64 ± 1.43 on the third day. In the control group the 
mean scores were 10.00 ± 0 on the first day, 8.80 ± 
1.14 in the second day and 7.50 ± 2.42 on the third 
day. The differences in functional disorder scores 
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between the study and control groups at days 1, 2 and 
3 after operation were 7.55, 7.07 and 5.86 
respectively.  
Table 6: Comparison of functional disorders between the two 
study groups at different follow-up periods 
 VAS for functional disorders 
Mean ± SD 
t-test p-value 
Study group Control group Difference 
1
st
 day after operation 2.45 ± 1.29 10.00 ± 0 7.55 
(6.68, 8.41) 
19.35 < 0.0001* 
2
nd
 day after operation 1.73 ± 1.43 8.80 ± 1.14 7.07 
(5.89, 8.26) 
12.52 < 0.0001* 
3
rd
 day after operation 1.64 ± 1.43 7.50 ± 2.42 5.86 
(3.99, 7.74) 
6.68 < 0.0001* 
Paired t test (1-2 days) 
p value 
2.67 
0.02* 
3.34 
0.01* 
   
Paired t test (1-3 days) 
p value 
3.11 
0.01* 
3.27 
0.01* 
   
*Statistically significant at p ≤ 0.05. 
 
In the study group, the decrease in the 
functional disorder scores between day 1 and day 2 
as well as between day 1 and day 3 was statistically 
significant (p = 0.02 and 0.01 respectively).  
 
Figure 3: Comparison of functional disorders between the two 
study groups at different follow-up periods 
 
In the control group, the differences between 
day 1 and day 2 as well as between day 1 and day 3 
were statistically significant (p = 0.01* for both). The 
differences between both groups at days 1, 2 and 3 
were statistically significant (p < 0.0001 for all). 
 
 
 
Discussion  
 
In our research, individuals on regular 
systemic steroid therapy or other immunosuppressant 
drugs were excluded to eliminate any effect of the 
drugs on ulcers healing or pain reduction. Also, 
teenagers, pregnant and postmenopausal women 
were prohibited from the study to avoid the effect of 
hormonal changes on the healing process. Also, 
smokers were not included because smoking 
increases the expression of TNF- α cytokine which 
has a role in aphthous ulceration [17]. 
 
Figure 4: Preoperative and postoperative treatment of MiRAS by 
diode laser in the study group; a) Minor aphthous lesion on lower 
labial mucosa before phototherapy; b) Minor aphthous lesion 
during phototherapy using diode laser 660 nm; c) the Fourth day of 
diode laser application; d) Sixth day of diode laser application 
 
The ages of enrolled individuals in our study 
ranged between 21-40 years for study and control 
groups with a mean age of 30.1 ± 6.9 and 28.1 ± 5.8 
respectively; it is the most common range in many 
studies [18], [19]. Nevertheless, sex and age 
distributions had no statistically significant differences 
between the study and control groups. 
 
Figure 5: MiRAS in lower labial mucosa of the control group; a) 
MiRAS on the lower labial mucosa (preoperative); b) fourth day of 
follow up visits; c) Sixth day of follow up visits 
 
In the present study, each patient in the 
control group (group A) received sodium bicarbonate 
mouth rinse as it provides a buffering activity to the 
acidic nature of the damaged mucosal cells and can 
decrease the pain [20]. While in the study group 
(group B), each patient received diode laser irradiation 
which was applied in the first visit only. Then, we 
compared VAS scores, ulcer sizes, effective indices 
and functional disorders between the two groups. 
On comparing the VAS pain score between 
the two study groups at different follow-up periods, 
statistically, significant differences were observed 
between both groups as all patients of the study group 
confirmed the complete or partial reduction of pain 
after a single session of the diode laser application. 
This may be due to the pain-relieving action of the 
laser therapy because the laser irradiation can reach 
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the exposed nerve endings easily, causing a blockage 
of nociceptive signals in primary afferent neurons and 
also can intensify the natural analgesics such as 
opioid peptides
,
 reduction by releasing histamine [21]. 
Also, the level of effectiveness index of pain 
reduction at day 4 in the study group showed 
complete healing in 9 cases and one case of 
moderate improvement while in control group, there 
was a moderate improvement in one case and no 
improvements in the other nine cases. However, at 
day 6, all cases in the study group had effectiveness 
index = "100" as the ten patients were completely 
healed as shown in Figure 4 (a, b, c, and d). While the 
mean in the control group was 48.00 ± 31.55 including 
2 complete healing cases, 5 moderate improved 
cases and 3 cases without any improvement as 
shown in Figure 5 (a, b, and c). The explanation of 
this decrease in effectiveness index in the control 
group is related to the liquid consistency that lacks the 
sticking potential on the mucosa for a long time 
causing a mild and momentary effect. 
These results were in agreement with a 
randomised controlled clinical trial which was 
conducted by Colvard and Kuo [22]
 
who used carbon 
dioxide laser in an ablative manner to treat RAS, but 
local anaesthesia was mandatory in their procedure. 
Also, our outcomes were in corresponding to Zand et 
al., [23], [24] and Prasad et al., [25] who evaluated the 
efficacy of a single-session, non-thermal, sub-ablative 
carbon dioxide laser irradiation in relieving the pain of 
MiRAS. These studies concluded that high power 
laser should be included as an alternative modality for 
the treatment of MiRAS, due to its ability of pain 
elimination. Nevertheless, our study was different as 
we used diode laser as LLLT in a non-ablative, non-
thermal manner and without anaesthesia.  
On comparison of the effectiveness index for 
ulcer size reduction between the two groups, the 
mean index at day 4 in the study and control groups 
were 64.20 ± 20.62 and 3.33 ± 10.54. In the study 
group, there were one completely healed lesion, three 
lesions with marked improvements and six lesions 
with moderate improvements in the ulcer sizes. While 
at day 6, they were 97.22 ± 8.33 and 53.06 ± 31.44 
respectively. The differences were statistically 
significant (p < 0.0001 and 0.001) respectively where 
a complete healing was reported in 8 patients, and 2 
patients showed marked improvements in the study 
group, on the contrary, the control group showed only 
one case with complete healing, one with marked 
improvement, six with moderate improvements and 
two patients didn’t show any improvement.  
These findings revealed that phototherapy 
had a higher effective index than sodium bicarbonate 
mouth rinse which in turn gave the superiority to diode 
laser in the reduction of ulcer size and pain. 
Regression of ulcer size and healing enhancement 
may be caused by the capillary vasodilation and re-
epithelization stimulation which increase the mitotic 
activity, the proliferation of fibroblasts, the collagen 
synthesis and the epithelial proliferation. Also, the 
host modulation effect of mast cells and the reduction 
of prostaglandin E2 promote healing activity [21], [26]. 
These outcomes were corresponding with Rodriguez 
et al., (27)
 
who measured the effectiveness index of 
ulcer’s size on day 0 (when the intervention began) 
and on treatment day 2 and 5 to evaluate the short-
term benefits of the intervention as RAS has a self-
limited natural history. Also, the findings were in 
accordance with De Souza et al., [28]
 
who reported 
that application of LLLT daily can reduce pain and 
regress the ulcers after four days as well as Khademi 
H et al., [29]
 
who revealed that there was a reduction 
in pain intensity and healing time when using LLLT 
than other treatments. 
Moreover, our findings were confirmed by 2 
clinical studies of diode laser; one was done by 
Aggarwal et al., [30] and Hazeem et al., [31] who used 
810 nm and 940 nm diode lasers in a controlled split-
mouth study and concluded that laser was effective in 
the healing process and pain relief. And the other 
study was done by Lalabonova et al., in 2014 [32] who 
conducted that 658nm diode laser with exposure time 
1.14 minutes can manage the pain and inflammation 
symptoms of the aphthous ulcer, but the documented 
long time was a disadvantage in their study because it 
increased the risk of health peril and time consuming 
on dental chair.  
The comparison of functional disorders 
between the two study groups at different follow up 
periods showed statistically significant (p < 0.0001*) 
between first, second, the third day after study 
procedures. These were in corresponding with Tezel 
[34]
 
who concluded that patients treated with the Nd: 
YAG laser had less post-treatment pain, fewer 
functional complications (eating and speech) and 
faster healing after 5 days. However, Nd: YAG laser 
required prolonged irradiation times (2-3 min) that 
may be a health hazard to the patient and the clinician 
[33], [34]. The outcomes of our present study showed 
that one application of diode laser 660 nm gave a 
more remarkable reduction in healing time, pain and 
lesion size than the sodium bicarbonate rinse, 
consequently, it is very effective in the treatment of 
RAS.  
In conclusion, despite the numerous 
therapeutic choices available for the management of 
RAS, there is no precise treatment due to the 
variegated causative factors of RAS. The 
effectiveness of its management depends on the 
acceleration time of relieving the sign and symptoms 
of the ulcers such as pain and inflammation. Our 
conclusions represent the diode laser 660 nm as an 
applicable effective alternative modality in the 
reduction of pain, ulcer size and healing time. 
However, the study sample reflected the findings in 
these enrolled groups of participants only, additional 
trails with larger samples are required to verify these 
outcomes.  
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